skip to main content
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: MEDLINE Complete remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia
Material Type:
Artigo
Adicionar ao Meu Espaço

Children's Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia

Dunsmore, Kimberly P ; Winter, Stuart S ; Devidas, Meenakshi ; Wood, Brent L ; Esiashvili, Natia ; Chen, Zhiguo ; Eisenberg, Nancy ; Briegel, Nikki ; Hayashi, Robert J ; Gastier-Foster, Julie M ; Carroll, Andrew J ; Heerema, Nyla A ; Asselin, Barbara L ; Rabin, Karen R ; Zweidler-Mckay, Patrick A ; Raetz, Elizabeth A ; Loh, Mignon L ; Schultz, Kirk R ; Winick, Naomi J ; Carroll, William L ; Hunger, Stephen P

Journal of clinical oncology, 2020-10, Vol.38 (28), p.3282-3293 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

2
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial

Venook, Alan P ; Niedzwiecki, Donna ; Lenz, Heinz-Josef ; Innocenti, Federico ; Fruth, Briant ; Meyerhardt, Jeffrey A ; Schrag, Deborah ; Greene, Claire ; O'Neil, Bert H ; Atkins, James Norman ; Berry, Scott ; Polite, Blase N ; O'Reilly, Eileen M ; Goldberg, Richard M ; Hochster, Howard S ; Schilsky, Richard L ; Bertagnolli, Monica M ; El-Khoueiry, Anthony B ; Watson, Peter ; Benson, Al B ; Mulkerin, Daniel L ; Mayer, Robert J ; Blanke, Charles

JAMA : the journal of the American Medical Association, 2017-06, Vol.317 (23), p.2392-2401 [Periódico revisado por pares]

United States: American Medical Association

Texto completo disponível

3
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial

Li, Qi-Jiong ; He, Min-Ke ; Chen, Huan-Wei ; Fang, Wan-Qiang ; Zhou, Yuan-Min ; Xu, Li ; Wei, Wei ; Zhang, Yao-Jun ; Guo, Ying ; Guo, Rong-Ping ; Chen, Min-Shan ; Shi, Ming

Journal of clinical oncology, 2022-01, Vol.40 (2), p.150-160 [Periódico revisado por pares]

United States

Texto completo disponível

4
Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313
Material Type:
Artigo
Adicionar ao Meu Espaço

Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313

Ramanathan, Ramesh K ; McDonough, Shannon L ; Philip, Philip A ; Hingorani, Sunil R ; Lacy, Jill ; Kortmansky, Jeremy S ; Thumar, Jaykumar ; Chiorean, E Gabriela ; Shields, Anthony F ; Behl, Deepti ; Mehan, Paul T ; Gaur, Rakesh ; Seery, Tara ; Guthrie, Katherine A ; Hochster, Howard S

Journal of clinical oncology, 2019-05, Vol.37 (13), p.1062-1069 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

5
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer
Material Type:
Artigo
Adicionar ao Meu Espaço

SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer

van Hazel, Guy A ; Heinemann, Volker ; Sharma, Navesh K ; Findlay, Michael P N ; Ricke, Jens ; Peeters, Marc ; Perez, David ; Robinson, Bridget A ; Strickland, Andrew H ; Ferguson, Tom ; Rodríguez, Javier ; Kröning, Hendrik ; Wolf, Ido ; Ganju, Vinod ; Walpole, Euan ; Boucher, Eveline ; Tichler, Thomas ; Shacham-Shmueli, Einat ; Powell, Alex ; Eliadis, Paul ; Isaacs, Richard ; Price, David ; Moeslein, Fred ; Taieb, Julien ; Bower, Geoff ; Gebski, Val ; Van Buskirk, Mark ; Cade, David N ; Thurston, Kenneth ; Gibbs, Peter

Journal of clinical oncology, 2016-05, Vol.34 (15), p.1723-1731 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

6
PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy
Material Type:
Artigo
Adicionar ao Meu Espaço

PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy

Gill, Sharlene ; Ko, Yoo-Joung ; Cripps, Christine ; Beaudoin, Annie ; Dhesy-Thind, Sukhbinder ; Zulfiqar, Muhammad ; Zalewski, Pawel ; Do, Thuan ; Cano, Pablo ; Lam, Wendy Yin Han ; Dowden, Scot ; Grassin, Helene ; Stewart, John ; Moore, Malcolm

Journal of clinical oncology, 2016-11, Vol.34 (32), p.3914-3920 [Periódico revisado por pares]

United States

Texto completo disponível

7
Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliary Tract Cancer (PRODIGE 38 AMEBICA): A Randomized Phase II Study
Material Type:
Artigo
Adicionar ao Meu Espaço

Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliary Tract Cancer (PRODIGE 38 AMEBICA): A Randomized Phase II Study

Phelip, Jean Marc ; Desrame, Jérôme ; Edeline, Julien ; Barbier, Emilie ; Terrebonne, Eric ; Michel, Pierre ; Perrier, Hervé ; Dahan, Laetitia ; Bourgeois, Vincent ; Akouz, Faiza Khemissa ; Soularue, Emilie ; Ly, Valérie Lebrun ; Molin, Yann ; Lecomte, Thierry ; Ghiringhelli, François ; Coriat, Romain ; Louafi, Samy ; Neuzillet, Cindy ; Manfredi, Sylvain ; Malka, David

Journal of clinical oncology, 2022-01, Vol.40 (3), p.262-271 [Periódico revisado por pares]

United States

Texto completo disponível

8
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Wang-Gillam, Andrea, MD ; Li, Chung-Pin, Prof ; Bodoky, György, Prof ; Dean, Andrew, MD ; Shan, Yan-Shen, Prof ; Jameson, Gayle, MSN ; Macarulla, Teresa, MD ; Lee, Kyung-Hun, MD ; Cunningham, David, Prof ; Blanc, Jean F, Prof ; Hubner, Richard A, PhD ; Chiu, Chang-Fang, Prof ; Schwartsmann, Gilberto, MD ; Siveke, Jens T, Prof ; Braiteh, Fadi, MD ; Moyo, Victor, MBBCh ; Belanger, Bruce, PhD ; Dhindsa, Navreet, DDS ; Bayever, Eliel, MBBCh ; Von Hoff, Daniel D, Prof ; Chen, Li-Tzong, Prof

The Lancet (British edition), 2016-02, Vol.387 (10018), p.545-557 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

9
Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Randomized Phase II Trial Evaluating Two Sequential Treatments in First Line of Metastatic Pancreatic Cancer: Results of the PANOPTIMOX-PRODIGE 35 Trial

Dahan, Laetitia ; Williet, Nicolas ; Le Malicot, Karine ; Phelip, Jean-Marc ; Desrame, Jérôme ; Bouché, Olivier ; Petorin, Caroline ; Malka, David ; Rebischung, Christine ; Aparicio, Thomas ; Lecaille, Cédric ; Rinaldi, Yves ; Turpin, Anthony ; Bignon, Anne-Laure ; Bachet, Jean-Baptiste ; Seitz, Jean-François ; Lepage, Come ; François, Eric

Journal of clinical oncology, 2021-10, Vol.39 (29), p.3242-3250 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

10
Second-Line Oxaliplatin, Folinic Acid, and Fluorouracil Versus Folinic Acid and Fluorouracil Alone for Gemcitabine-Refractory Pancreatic Cancer: Outcomes From the CONKO-003 Trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Second-Line Oxaliplatin, Folinic Acid, and Fluorouracil Versus Folinic Acid and Fluorouracil Alone for Gemcitabine-Refractory Pancreatic Cancer: Outcomes From the CONKO-003 Trial

OETTLE, Helmut ; RIESS, Hanno ; BISCHOFF, Sven ; SINN, Marianne ; DÖRKEN, Bernd ; PELZER, Uwe ; STIELER, Jens M ; HEIL, Gerhard ; SCHWANER, Ingo ; SERAPHIN, Jörg ; GÖRNER, Martin ; MÖLLE, Matthias ; GRETEN, Tim F ; LAKNER, Volker

Journal of clinical oncology, 2014-08, Vol.32 (23), p.2423-2429 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (1.239)
  2. Revistas revisadas por pares (1.497)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (1.577)
  2. magazinearticle  (1)
  3. Mais opções open sub menu

Data de Publicação 

De até
  1. Antes de1980  (20)
  2. 1980Até1990  (104)
  3. 1991Até2001  (351)
  4. 2002Até2013  (692)
  5. Após 2013  (412)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (1.555)
  2. Japonês  (152)
  3. Russo  (12)
  4. Alemão  (9)
  5. Espanhol  (5)
  6. Francês  (2)
  7. Norueguês  (2)
  8. Coreano  (1)
  9. Chinês  (1)
  10. Mais opções open sub menu

Buscando em bases de dados remotas. Favor aguardar.